Skip to content

The Incremental Risk of Intraoperative Fentanyl on PONV

The Incremental Risk of Intraoperative Fentanyl on PONV: A Modifiable Risk Without Drawbacks?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03201315
Enrollment
363
Registered
2017-06-28
Start date
2017-01-01
Completion date
2017-05-31
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PONV

Keywords

Fentanyl, opioids

Brief summary

The aim of this quality control study is to describe the presence and intensity of postoperative nausea and vomiting (PONV) and its correlation with intraoperative fentanyl dosing. Additionally, the investigators will examine pain scores.

Detailed description

The primary aims of this quality control study are: 1. to determine whether there is an independent association between the intraoperative administration of fentanyl (both as a continuous and categorical variable) and PONV within 24 postoperative hours 2. determine whether or not the intraoperative fentanyl amount can be used to successfully restratify patients for PONV beyond the simplified Apfel score for PONV All required data is collected in regular daily practice. The following variables will be assessed by univariable models: Preoperative variables (e.g. patient characteristics) Surgical/Anesthesia variables (e.g. type/length of surgery, antiemetics) Outcome variables (PONV, worst pain as delineated in the outcomes section), Intraoperative fentanyl measured 1) as a continuous variable and 2) by predefined limits of 0 to 0.2mg, \>0.2-0.5mg, \>0.5 to 0.8mg, and \>8mg. Finally for the multivariable model, the investigators will adjust for confounders, specifically for sex (m/f), history (Hx) of PONV (y/n), Hx of motion sickness (y/n), current smoker (y/n), age (years), expected duration of surgery (min; \>60 min), postoperative opioids (y/n), the use of preemptive PONV Therapy (0,1,2 medications), propofol vs. inhalative agents (y/n), and surgery type (3 kinds) from the patient's electronic record. In the event that insufficient event rates are observed, we will collapse the variables into the simplified Apfel score to assess the independent value of fentanyl in predicting PONV. In addition to a logistic model as delineated above, we will conduct the following: 1. receiver operating characteristic (ROC) curves of the logistic model without fentanyl, with fentanyl (continuous), and with fentanyl (categorical). 2. additionally, ROCs of a simplified model using the Apfel score, the Apfel score with fentanyl (continous), and the Apfel score with fentanyl (categorical) will be made. Comparison of area under the receiver operating characteristics(AUROCs) by DeLong 3. net reclassification improvement (NRI) of both the logistic model with and without fentanyl as well as the Apfel score with and without fentanyl To assess pain and administered fentanyl, we will examine pain scores by the numeric rating scale (NRS).

Interventions

None listed

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* In-patients with an expected simplified Apfel score of 2 or higher, * Aged \>= 18 years, and * Undergoing general anesthesia (with or without neuraxial or regional anesthesia.) * in abdominal, gynecological or otorhinolaryngological surgery

Exclusion criteria

* Outpatients * Patients with chronic pain, defined as recurring pain requiring intermittent hospitalization or regular intake of pain medication. * Non-opioid naïve patients, defined as a history of abuse or having taken opioids within the last 30 days

Design outcomes

Primary

MeasureTime frameDescription
Any postoperative nausea and/or vomiting (PONV) within 24 hours after surgerywithin 24 hours (or next morning discharge)postoperative nausea and/or vomiting (PONV) yes/no (either by chart or by patient confirmation) within 24 hours (or next morning discharge)

Secondary

MeasureTime frameDescription
number of postoperative vomiting events within 24 hourswithin 24 hours (or next morning discharge)Number of times vomiting (0, 1-2, \>3 times; either by chart or by patient confirmation) within 24 hours (or next morning discharge)
Any postoperative nausea and/or vomiting (PONV) while in the recovery roomfirst two postoperative hoursPostoperative nausea and/or vomiting (PONV) yes/no (either by chart or by patient confirmation) while in recovery room
Worst pain, i.e. highest Numeric Rating Score (NRS)within 24 hours / in recovery room (first two postoperative hours)highest / worst pain score within 24 hours / in recovery room (defined as above)

Other

MeasureTime frameDescription
Dose of postoperative administration of opioidswithin 24 hours / in recovery room (first two postoperative hours)quantification of postoperative administration of opioids 24 hours/recovery room

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026